Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial

OBJECTIVES: The aim of this trial is to evaluate the antiviral efficacy, clinical efficacy, and safety of nelfinavir in patients with asymptomatic and mild COVID-19. TRIAL DESIGN: The study is designed as a multicenter, open-label, blinded outcome assessment, parallel group, investigator-initiated,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosogaya, Naoki, Miyazaki, Taiga, Fukushige, Yuri, Takemori, Sachiko, Morimoto, Shinpei, Yamamoto, Hiroshi, Hori, Makoto, Kurokawa, Tomoya, Kawasaki, Yohei, Hanawa, Michiko, Fujii, Yasuhisa, Hanaoka, Hideki, Iwami, Shingo, Watashi, Koichi, Yamagoe, Satoshi, Miyazaki, Yoshitsugu, Wakita, Takaji, Izumikawa, Koichi, Yanagihara, Katsunori, Mukae, Hiroshi, Kohno, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080096/
https://www.ncbi.nlm.nih.gov/pubmed/33910617
http://dx.doi.org/10.1186/s13063-021-05282-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080096/
https://www.ncbi.nlm.nih.gov/pubmed/33910617
http://dx.doi.org/10.1186/s13063-021-05282-w

Ejemplares similares